About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- 1,637 postmenopausal women with prior vertebral fractures
- Sample size
- 1637
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Placebo-controlled, so it does not compare teriparatide with other osteoporosis drugs. Median observation was 21 months. The abstract does not state the funder.
Cited in
Fractures versus placebo
Teriparatide · Research finding
Strong
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.